The store will not work correctly when cookies are disabled.
N-(4-amino-3-(trifluoromethyl)phenyl)biphenyl-4-sulfonamide
ID: ALA4744260
PubChem CID: 162645736
Max Phase: Preclinical
Molecular Formula: C19H15F3N2O2S
Molecular Weight: 392.40
Molecule Type: Unknown
Associated Items:
Names and Identifiers
Canonical SMILES: Nc1ccc(NS(=O)(=O)c2ccc(-c3ccccc3)cc2)cc1C(F)(F)F
Standard InChI: InChI=1S/C19H15F3N2O2S/c20-19(21,22)17-12-15(8-11-18(17)23)24-27(25,26)16-9-6-14(7-10-16)13-4-2-1-3-5-13/h1-12,24H,23H2
Standard InChI Key: NAZYSPXPKMRCHP-UHFFFAOYSA-N
Molfile:
RDKit 2D
27 29 0 0 0 0 0 0 0 0999 V2000
5.3943 -21.5978 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
4.9898 -20.8920 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
4.5809 -21.5952 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
6.4082 -20.8920 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.4070 -21.7115 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.1151 -22.1205 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.8247 -21.7111 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.8219 -20.8884 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.1133 -20.4831 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.7004 -20.4836 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
4.2849 -20.4839 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.2884 -19.6661 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.5814 -19.2578 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.8728 -19.6666 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.8756 -20.4880 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.5832 -20.8927 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.5331 -22.1185 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
7.1149 -22.9377 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.4071 -23.3461 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
7.8225 -23.3465 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
7.1071 -23.7522 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
2.1645 -19.2591 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.1636 -18.4423 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.4561 -18.0349 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.7481 -18.4447 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.7520 -19.2661 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.4601 -19.6698 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 1 2 0
3 2 2 0
4 5 2 0
5 6 1 0
6 7 2 0
7 8 1 0
8 9 2 0
9 4 1 0
4 10 1 0
10 2 1 0
2 11 1 0
11 12 2 0
12 13 1 0
13 14 2 0
14 15 1 0
15 16 2 0
16 11 1 0
7 17 1 0
6 18 1 0
18 19 1 0
18 20 1 0
18 21 1 0
14 22 1 0
22 23 2 0
23 24 1 0
24 25 2 0
25 26 1 0
26 27 2 0
27 22 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 392.40 | Molecular Weight (Monoisotopic): 392.0806 | AlogP: 4.76 | #Rotatable Bonds: 4 |
Polar Surface Area: 72.19 | Molecular Species: NEUTRAL | HBA: 3 | HBD: 2 |
#RO5 Violations: ┄ | HBA (Lipinski): 4 | HBD (Lipinski): 3 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 8.26 | CX Basic pKa: 2.37 | CX LogP: 4.16 | CX LogD: 4.11 |
Aromatic Rings: 3 | Heavy Atoms: 27 | QED Weighted: 0.63 | Np Likeness Score: -1.36 |
References
1. Xu F,Zhao Y,Zhou H,Li C,Zhang X,Hou T,Qu L,Wei L,Wang J,Liu Y,Liang X. (2020) Synthesis and evaluation of 3-(4-(phenoxymethyl)phenyl)propanoic acid and N-phenylbenzenesulfonamide derivatives as FFA4 agonists., 30 (24): [PMID:33127539] [10.1016/j.bmcl.2020.127650] |